
Inflammatix
@inflammatix_inc
Our expertise in reading a patient’s immune response led to TriVerity™, an IVD test for patients with suspected acute infection or sepsis.
ID: 836331836565442560
http://www.inflammatix.com 27-02-2017 21:47:02
662 Tweet
1,1K Takipçi
2,2K Takip Edilen


Great turnout for the Sepsis Alliance webinar hosted by our CMO Sam Ajizian, "Advances in Emergency Medicine Diagnostic Testing: Reducing Clinical Ambiguity in Patients Suspected of Acute Infections and Sepsis" Watch the recorded webinar here: learn.sepsis.org/products/infla…

Surviving sepsis is just the beginning. This Sepsis Survivor Week, we honor survivors and the unseen struggles they face after leaving the hospital. #SepsisSurvivor Sepsis Alliance


Thanks to Stanford Medicine for interviewing Purvesh Khatri to tell the TriVerity story following its recent FDA clearance, which started in Dr. Khatri's lab with Tim Sweeney a decade ago. Their pioneering work led them and Jonathan Romanowsky to cofound Inflammatix in 2016. Great read!

Our CEO and Co-Founder Tim Sweeney comments on the potential of AI to reshape healthcare in Science News - see section "AI could calculate health risks from patient data" sciencenews.org/article/ai-hea…


Join us at the Critical Care Congress #SCCM2025 in Orlando, or virtually, for an oral presentation by Tim Sweeney - go here to register sccm.org/annual-congres…


Sepsis treatment isn’t one-size-fits-all, as a study in Critical Care Medicine shows, treatment response varies widely across #sepsis patients. By leveraging gene expression, we can push precision medicine forward in critical care. journals.lww.com/ccmjournal/ful…

This Patient Safety Awareness Week, we join Institute for Healthcare Improvement (IHI) to Move the Needle together by offering the healthcare community better tools to improve patient safety in patients suspected of acute infections and sepsis. #PatientSafety #ptsafety #sepsis


Our Co-founder and Chief Scientist Purvesh Khatri will join a panel tomorrow at Precision Med TRI-CON to discuss the power of host-response profiling, including how its ready for prime time now in its ability to improve patient care. See details: triconference.com/infectious-dis…



We’re honored to announce that we have signed a contract with the JPEO-CBRND to help the U.S. military detect the presence and assess the severity of acute infections or sepsis under battlefield conditions. Read today’s announcement: inflammatix.com/inflammatix-sh… #Sepsis #Diagnostics





